Sasaki K, Chida K, Hashiba H, Kamata N, Abe E, Suda T, Kuroki T
Cancer Res. 1986 Feb;46(2):604-10.
We reported previously that 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25(OH)2D3], a hormonally active form of vitamin D3, markedly enhanced methylcholanthrene-induced transformation of BALB 3T3 A31-1-1 cells. When the cells were treated with methylcholanthrene (1 microgram/ml) for 72 h and then with 1 alpha,25(OH)2D3 (5 ng/ml) for 2 wk, the transformation frequency was 1.95 +/- 0.73 (SD) foci/dish in 8 independent experiments, which was about 20 times that in cultures treated with methylcholanthrene only. Even at a physiological concentration in plasma, i.e., 0.05 ng/ml, 1 alpha,25(OH)2D3 enhanced the transformation frequency significantly (P less than 0.001). 1 alpha,25(OH)2D3 was not cytotoxic but slightly inhibited growth of the cells. Cells treated with 1 alpha,25(OH)2D3 were thin and became arranged in a meshwork with wide intercellular spaces. These morphological changes were reversible. 1 alpha,25(OH)2D3 induced DNA synthesis in quiescent BALB 3T3 cells dose and time dependently, but this effect was less than that of 12-O-tetradecanoylphorbol-13-acetate. Unlike 12-O-tetradecanoylphorbol-13-acetate, 1 alpha,25(OH)2D3 did not interfere with the binding of epidermal growth factor or phorbol dibutyrate. 1 alpha,25(OH)2D3 did not induce ornithine decarboxylase. Moreover, it did not activate protein kinase C in quiescent BALB 3T3 cells or this enzyme isolated from mouse brain. BALB 3T3 cells and their transformants contain a specific cytosol receptor for 1 alpha,25(OH)2D3, but the binding sites of the transformants were fewer and had lower affinity than those of untransformed BALB 3T3 cells. These effects of 1 alpha,25(OH)2D3 were specific, because other derivatives of vitamin D3 induced the same effects only at 200 times or more higher concentrations.
我们之前报道过,1α,25 - 二羟基维生素D3 [1α,25(OH)2D3],维生素D3的一种激素活性形式,能显著增强甲基胆蒽诱导的BALB 3T3 A31 - 1 - 1细胞的转化。当细胞用甲基胆蒽(1微克/毫升)处理72小时,然后用1α,25(OH)2D3(5纳克/毫升)处理2周时,在8个独立实验中转化频率为1.95±0.73(标准差)集落/培养皿,这大约是仅用甲基胆蒽处理的培养物中的20倍。即使在血浆中的生理浓度,即0.05纳克/毫升时,1α,25(OH)2D3也能显著提高转化频率(P小于0.001)。1α,25(OH)2D3没有细胞毒性,但对细胞生长有轻微抑制作用。用1α,25(OH)2D3处理的细胞变薄,并排列成具有宽细胞间隙的网状结构。这些形态变化是可逆的。1α,25(OH)2D3剂量和时间依赖性地诱导静止的BALB 3T3细胞中的DNA合成,但这种作用小于12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯。与12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯不同,1α,25(OH)2D3不干扰表皮生长因子或佛波醇二丁酸酯的结合。1α,25(OH)2D3不诱导鸟氨酸脱羧酶。此外,它在静止的BALB 3T3细胞或从小鼠脑中分离的这种酶中不激活蛋白激酶C。BALB 3T3细胞及其转化体含有1α,25(OH)2D3的特异性胞质受体,但转化体的结合位点比未转化的BALB 3T3细胞少且亲和力低。1α,25(OH)2D3的这些作用是特异性的,因为维生素D3的其他衍生物仅在200倍或更高浓度时才诱导相同的作用。